![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Publisher: Bentham Science Publishers
E-ISSN: 1873-4286|17|34|3797-3804
ISSN: 1381-6128
Source: Current Pharmaceutical Design, Vol.17, Iss.34, 2011-01, pp. : 3797-3804
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Mast Cells as Targets of Pimecrolimus
Current Pharmaceutical Design, Vol. 17, Iss. 34, 2011-11 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
By Norris Alan
Expert Opinion on Investigational Drugs, Vol. 13, Iss. 7, 2004-07 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
By Oliver J.M. Kepley C.L. Ortega E. Wilson B.S.
Immunopharmacology, Vol. 48, Iss. 3, 2000-07 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Mast Cells: Target and Source of Neuropeptides
Current Pharmaceutical Design, Vol. 15, Iss. 29, 2009-10 ,pp. :